| abstract |
Disclosed are phenyloxazolidinones of general formula (I), wherein R1 is H, (C1-C8)alkyl, optionally substituted by at least one substituent selected from the group comprising F, Cl, hydroxy, alkoxy, acyloxy, (C3-C6)cycloalkyl, amino, (C1-C8)alkylamino, (C1-C8)dialkylamino, (C1-C8)alkoxy, R2 and R3 are same or different and are selected from the group, which is made by hydrogen, fluorine, chlorine, (C1-C8)alkyl, trifluoromethyl, hydroxy, (C1-C8)alkoxy, nitro, amino, providing that, when R2 and R3 are both different than hydrogen, then R2 and R3 are same, R4 is selected from the group made of residues a, b, c and d, the meaning of other substituents is stated in disclosure and their pharmaceutically acceptable salts and hydrates. |